VREX Quote, Financials, Valuation and Earnings

Hologic has a net margin of -0.15% compared to Varex Imaging's net margin of -1.73%. Varex Imaging's return on equity of -8.27% beat Hologic's return on equity of 11.45%.

Varex Imaging has a consensus price target of $21.20, signalling upside risk potential of 156.66%. On the other hand Hologic has an analysts' consensus of $67.96 which suggests that it could grow by 27.96%. Given that Varex Imaging has higher upside potential than Hologic, analysts believe Varex Imaging is more attractive than Hologic.

Varex Imaging has a beta of 0.617, which suggesting that the stock is 38.305% less volatile than S&P 500. In comparison Hologic has a beta of 0.544, suggesting its less volatile than the S&P 500 by 45.552%.

Varex Imaging has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hologic offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Varex Imaging pays -- of its earnings as a dividend. Hologic pays out -- of its earnings as a dividend.

Varex Imaging quarterly revenues are $199.8M, which are smaller than Hologic quarterly revenues of $1B. Varex Imaging's net income of -$300K is higher than Hologic's net income of -$17.4M. Notably, Varex Imaging's price-to-earnings ratio is 17.58x while Hologic's PE ratio is 22.41x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Varex Imaging is 0.41x versus 3.07x for Hologic. Usually stocks with elevated PS ratios are considered overvalued.

Nuwellis has a net margin of -0.15% compared to Varex Imaging's net margin of -63.22%. Varex Imaging's return on equity of -8.27% beat Nuwellis's return on equity of -800.59%.

Varex Imaging has a consensus price target of $21.20, signalling upside risk potential of 156.66%. On the other hand Nuwellis has an analysts' consensus of $13.00 which suggests that it could grow by 1282.08%. Given that Nuwellis has higher upside potential than Varex Imaging, analysts believe Nuwellis is more attractive than Varex Imaging.

Varex Imaging has a beta of 0.617, which suggesting that the stock is 38.305% less volatile than S&P 500. In comparison Nuwellis has a beta of 0.505, suggesting its less volatile than the S&P 500 by 49.478%.

Varex Imaging has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nuwellis offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Varex Imaging pays -- of its earnings as a dividend. Nuwellis pays out -- of its earnings as a dividend.

Varex Imaging quarterly revenues are $199.8M, which are larger than Nuwellis quarterly revenues of $2.3M. Varex Imaging's net income of -$300K is higher than Nuwellis's net income of -$1.5M. Notably, Varex Imaging's price-to-earnings ratio is 17.58x while Nuwellis's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Varex Imaging is 0.41x versus 0.17x for Nuwellis. Usually stocks with elevated PS ratios are considered overvalued.

Quanterix has a net margin of -0.15% compared to Varex Imaging's net margin of -34.09%. Varex Imaging's return on equity of -8.27% beat Quanterix's return on equity of -11.35%.

Varex Imaging has a consensus price target of $21.20, signalling upside risk potential of 156.66%. On the other hand Quanterix has an analysts' consensus of $12.13 which suggests that it could grow by 126.64%. Given that Varex Imaging has higher upside potential than Quanterix, analysts believe Varex Imaging is more attractive than Quanterix.

Varex Imaging has a beta of 0.617, which suggesting that the stock is 38.305% less volatile than S&P 500. In comparison Quanterix has a beta of 1.116, suggesting its more volatile than the S&P 500 by 11.641%.

Varex Imaging has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quanterix offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Varex Imaging pays -- of its earnings as a dividend. Quanterix pays out -- of its earnings as a dividend.

Varex Imaging quarterly revenues are $199.8M, which are larger than Quanterix quarterly revenues of $34.1M. Varex Imaging's net income of -$300K is higher than Quanterix's net income of -$11.6M. Notably, Varex Imaging's price-to-earnings ratio is 17.58x while Quanterix's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Varex Imaging is 0.41x versus 1.52x for Quanterix. Usually stocks with elevated PS ratios are considered overvalued.

TransMedics Group has a net margin of -0.15% compared to Varex Imaging's net margin of 5.64%. Varex Imaging's return on equity of -8.27% beat TransMedics Group's return on equity of 19.17%.

Varex Imaging has a consensus price target of $21.20, signalling upside risk potential of 156.66%. On the other hand TransMedics Group has an analysts' consensus of $105.29 which suggests that it could grow by 12.75%. Given that Varex Imaging has higher upside potential than TransMedics Group, analysts believe Varex Imaging is more attractive than TransMedics Group.

Varex Imaging has a beta of 0.617, which suggesting that the stock is 38.305% less volatile than S&P 500. In comparison TransMedics Group has a beta of 1.906, suggesting its more volatile than the S&P 500 by 90.573%.

Varex Imaging has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. TransMedics Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Varex Imaging pays -- of its earnings as a dividend. TransMedics Group pays out -- of its earnings as a dividend.

Varex Imaging quarterly revenues are $199.8M, which are larger than TransMedics Group quarterly revenues of $121.6M. Varex Imaging's net income of -$300K is lower than TransMedics Group's net income of $6.9M. Notably, Varex Imaging's price-to-earnings ratio is 17.58x while TransMedics Group's PE ratio is 92.46x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Varex Imaging is 0.41x versus 7.45x for TransMedics Group. Usually stocks with elevated PS ratios are considered overvalued.